Does the media favor AMWL or DRIO?

In the previous week, DarioHealth had 2 more articles in the media than American Well. MarketBeat recorded 5 mentions for DarioHealth and 3 mentions for American Well. American Well's average media sentiment score of 1.08 beat DarioHealth's score of 0.20 indicating that American Well is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment American Well 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DarioHealth 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer DRIO or HCAT?

In the previous week, DarioHealth had 4 more articles in the media than Health Catalyst. MarketBeat recorded 5 mentions for DarioHealth and 1 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.59 beat DarioHealth's score of 0.20 indicating that Health Catalyst is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DarioHealth 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Health Catalyst 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is OPRX or DRIO more profitable?

OptimizeRx has a net margin of 4.66% compared to DarioHealth's net margin of -169.87%. OptimizeRx's return on equity of 9.44% beat DarioHealth's return on equity. Company Net Margins Return on Equity Return on Assets OptimizeRx 4.66% 9.44% 7.11% DarioHealth -169.87% -54.81% -33.36%

Does the media favor OPRX or DRIO?

In the previous week, DarioHealth had 4 more articles in the media than OptimizeRx. MarketBeat recorded 5 mentions for DarioHealth and 1 mentions for OptimizeRx. DarioHealth's average media sentiment score of 0.20 beat OptimizeRx's score of 0.00 indicating that DarioHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DarioHealth 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation and earnings, CCLD or DRIO?

CareCloud has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareCloud $120.50M 0.89 $10.80M $0.07 35.86 DarioHealth $22.36M 3.28 -$41.71M -$6.13 N/A

Is CCLD or DRIO more profitable?

CareCloud has a net margin of 6.21% compared to DarioHealth's net margin of -169.87%. CareCloud's return on equity of 27.07% beat DarioHealth's return on equity. Company Net Margins Return on Equity Return on Assets CareCloud 6.21% 27.07% 14.56% DarioHealth -169.87% -54.81% -33.36%

Does the media prefer CCLD or DRIO?

In the previous week, DarioHealth had 2 more articles in the media than CareCloud. MarketBeat recorded 5 mentions for DarioHealth and 3 mentions for CareCloud. CareCloud's average media sentiment score of 0.33 beat DarioHealth's score of 0.20 indicating that CareCloud is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareCloud 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral DarioHealth 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to DRIO or DH?

In the previous week, DarioHealth had 1 more articles in the media than Definitive Healthcare. MarketBeat recorded 5 mentions for DarioHealth and 4 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.26 beat DarioHealth's score of 0.20 indicating that Definitive Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DarioHealth 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Definitive Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

DarioHealth (DRIO) Competitors

$7.49 0.00 (0.00%)

As of 08/21/2026 04:00 PM Eastern

Compare

DRIO vs. AMWL, HCAT, OPRX, CCLD, and DH

Should you buy DarioHealth stock or one of its competitors? DarioHealth's main competitors and comparable companies include American Well (AMWL), Health Catalyst (HCAT), OptimizeRx (OPRX), CareCloud (CCLD), and Definitive Healthcare (DH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does DarioHealth compare to American Well?

American Well (NYSE:AMWL) and DarioHealth (NASDAQ:DRIO) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.

DarioHealth has lower revenue, but higher earnings than American Well. American Well is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.79	-$95.70M	-$4.77	N/A
DarioHealth	$22.36M	3.28	-$41.71M	-$6.13	N/A

American Well has a net margin of -35.75% compared to DarioHealth's net margin of -169.87%. American Well's return on equity of -30.12% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
DarioHealth	-169.87%	-54.81%	-33.36%

American Well presently has a consensus target price of $9.50, indicating a potential downside of 19.76%. DarioHealth has a consensus target price of $10.00, indicating a potential upside of 33.51%. Given DarioHealth's stronger consensus rating and higher possible upside, analysts clearly believe DarioHealth is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

56.1% of American Well shares are held by institutional investors. Comparatively, 33.4% of DarioHealth shares are held by institutional investors. 12.8% of American Well shares are held by company insiders. Comparatively, 3.5% of DarioHealth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, DarioHealth had 2 more articles in the media than American Well. MarketBeat recorded 5 mentions for DarioHealth and 3 mentions for American Well. American Well's average media sentiment score of 1.08 beat DarioHealth's score of 0.20 indicating that American Well is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
American Well	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DarioHealth	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

American Well has a beta of 1.68, indicating that its stock price is 68% more volatile than the broader market. Comparatively, DarioHealth has a beta of 1.11, indicating that its stock price is 11% more volatile than the broader market.

Summary

American Well beats DarioHealth on 9 of the 16 factors compared between the two stocks.

How does DarioHealth compare to Health Catalyst?

DarioHealth (NASDAQ:DRIO) and Health Catalyst (NASDAQ:HCAT) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

33.4% of DarioHealth shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 3.5% of DarioHealth shares are owned by company insiders. Comparatively, 19.4% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

DarioHealth has a beta of 1.11, suggesting that its stock price is 11% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.55, suggesting that its stock price is 55% more volatile than the broader market.

Health Catalyst has a net margin of -90.61% compared to DarioHealth's net margin of -169.87%. Health Catalyst's return on equity of -1.83% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
Health Catalyst	-90.61%	-1.83%	-0.80%

In the previous week, DarioHealth had 4 more articles in the media than Health Catalyst. MarketBeat recorded 5 mentions for DarioHealth and 1 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.59 beat DarioHealth's score of 0.20 indicating that Health Catalyst is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DarioHealth	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Health Catalyst	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DarioHealth currently has a consensus target price of $10.00, suggesting a potential upside of 33.51%. Health Catalyst has a consensus target price of $2.82, suggesting a potential upside of 84.49%. Given Health Catalyst's higher probable upside, analysts plainly believe Health Catalyst is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Health Catalyst	1 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.15

DarioHealth has higher earnings, but lower revenue than Health Catalyst. DarioHealth is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36M	3.28	-$41.71M	-$6.13	N/A
Health Catalyst	$311.14M	0.37	-$177.97M	-$3.68	N/A

Summary

Health Catalyst beats DarioHealth on 12 of the 16 factors compared between the two stocks.

How does DarioHealth compare to OptimizeRx?

OptimizeRx (NASDAQ:OPRX) and DarioHealth (NASDAQ:DRIO) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

76.5% of OptimizeRx shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 7.5% of OptimizeRx shares are owned by insiders. Comparatively, 3.5% of DarioHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

OptimizeRx currently has a consensus price target of $11.43, indicating a potential upside of 48.23%. DarioHealth has a consensus price target of $10.00, indicating a potential upside of 33.51%. Given OptimizeRx's stronger consensus rating and higher possible upside, equities research analysts clearly believe OptimizeRx is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

OptimizeRx has a net margin of 4.66% compared to DarioHealth's net margin of -169.87%. OptimizeRx's return on equity of 9.44% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
DarioHealth	-169.87%	-54.81%	-33.36%

OptimizeRx has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market. Comparatively, DarioHealth has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market.

In the previous week, DarioHealth had 4 more articles in the media than OptimizeRx. MarketBeat recorded 5 mentions for DarioHealth and 1 mentions for OptimizeRx. DarioHealth's average media sentiment score of 0.20 beat OptimizeRx's score of 0.00 indicating that DarioHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DarioHealth	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

OptimizeRx has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$98.65M	1.47	$5.13M	$0.23	33.52
DarioHealth	$22.36M	3.28	-$41.71M	-$6.13	N/A

Summary

OptimizeRx beats DarioHealth on 12 of the 16 factors compared between the two stocks.

How does DarioHealth compare to CareCloud?

CareCloud (NASDAQ:CCLD) and DarioHealth (NASDAQ:DRIO) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

In the previous week, DarioHealth had 2 more articles in the media than CareCloud. MarketBeat recorded 5 mentions for DarioHealth and 3 mentions for CareCloud. CareCloud's average media sentiment score of 0.33 beat DarioHealth's score of 0.20 indicating that CareCloud is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareCloud	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
DarioHealth	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 14.8% of CareCloud shares are owned by company insiders. Comparatively, 3.5% of DarioHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

CareCloud has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.89	$10.80M	$0.07	35.86
DarioHealth	$22.36M	3.28	-$41.71M	-$6.13	N/A

CareCloud currently has a consensus target price of $3.25, indicating a potential upside of 29.48%. DarioHealth has a consensus target price of $10.00, indicating a potential upside of 33.51%. Given DarioHealth's higher probable upside, analysts clearly believe DarioHealth is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

CareCloud has a beta of 1.51, meaning that its stock price is 51% more volatile than the broader market. Comparatively, DarioHealth has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market.

CareCloud has a net margin of 6.21% compared to DarioHealth's net margin of -169.87%. CareCloud's return on equity of 27.07% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	6.21%	27.07%	14.56%
DarioHealth	-169.87%	-54.81%	-33.36%

Summary

CareCloud beats DarioHealth on 11 of the 16 factors compared between the two stocks.

How does DarioHealth compare to Definitive Healthcare?

DarioHealth (NASDAQ:DRIO) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

DarioHealth has higher earnings, but lower revenue than Definitive Healthcare. DarioHealth is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36M	3.28	-$41.71M	-$6.13	N/A
Definitive Healthcare	$241.52M	0.32	-$138.93M	-$1.60	N/A

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 3.5% of DarioHealth shares are held by insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Definitive Healthcare has a net margin of -72.28% compared to DarioHealth's net margin of -169.87%. Definitive Healthcare's return on equity of 3.55% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
Definitive Healthcare	-72.28%	3.55%	1.63%

In the previous week, DarioHealth had 1 more articles in the media than Definitive Healthcare. MarketBeat recorded 5 mentions for DarioHealth and 4 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.26 beat DarioHealth's score of 0.20 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DarioHealth	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Definitive Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

DarioHealth currently has a consensus target price of $10.00, suggesting a potential upside of 33.51%. Definitive Healthcare has a consensus target price of $1.47, suggesting a potential upside of 106.05%. Given Definitive Healthcare's higher possible upside, analysts plainly believe Definitive Healthcare is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Definitive Healthcare	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.89

DarioHealth has a beta of 1.11, suggesting that its stock price is 11% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market.

Summary

Definitive Healthcare beats DarioHealth on 12 of the 17 factors compared between the two stocks.

Get DarioHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DRIO vs. The Competition

Export

Metric	DarioHealth	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$73.40M	$1.72B	$7.32B	$12.82B
Dividend Yield	N/A	4.69%	2.54%	10.78%
P/E Ratio	-1.22	21.44	272.91	24.33
Price / Sales	3.28	76.13	639.20	97.25
Price / Cash	N/A	31.69	29.03	36.90
Price / Book	0.75	5.78	11.38	6.42
Net Income	-$41.71M	-$18.66M	$3.47B	$348.89M
7 Day Performance	1.77%	1.82%	2.16%	0.51%
1 Month Performance	-3.85%	12.86%	7.59%	4.84%
1 Year Performance	-34.31%	-17.02%	25.16%	17.04%

DarioHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DRIO DarioHealth	3.7478 of 5 stars	$7.49 flat	$10.00 +33.5%	-34.3%	$73.40M	$22.36M	N/A	200	Gap Down
AMWL American Well	2.9232 of 5 stars	$12.53 -3.5%	$8.60 -31.4%	+65.2%	$207.40M	$218.53M	N/A	1,040	Positive News
HCAT Health Catalyst	3.1431 of 5 stars	$1.80 +2.3%	$2.95 +64.1%	-53.4%	$135.46M	$292.25M	N/A	1,200	Gap Down
OPRX OptimizeRx	3.693 of 5 stars	$7.12 +2.9%	$13.43 +88.6%	-55.3%	$133.61M	$107.35M	20.34	100	Gap Up
CCLD CareCloud	3.8465 of 5 stars	$2.45 +0.4%	$3.25 +32.7%	-11.3%	$104.10M	$120.50M	35.00	3,650

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DRIO) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DarioHealth (DRIO) Competitors

DRIO vs. AMWL, HCAT, OPRX, CCLD, and DH

How does DarioHealth compare to American Well?

Summary

How does DarioHealth compare to Health Catalyst?

Summary

How does DarioHealth compare to OptimizeRx?

Summary

How does DarioHealth compare to CareCloud?

Summary

How does DarioHealth compare to Definitive Healthcare?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DRIO vs. The Competition

DarioHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DarioHealth (DRIO) Competitors

DRIO vs. AMWL, HCAT, OPRX, CCLD, and DH

How does DarioHealth compare to American Well?

Which has better valuation and earnings, AMWL or DRIO?

Is AMWL or DRIO more profitable?

Do analysts recommend AMWL or DRIO?

Do institutionals and insiders believe in AMWL or DRIO?

Does the media favor AMWL or DRIO?

Which has more risk and volatility, AMWL or DRIO?

Summary

How does DarioHealth compare to Health Catalyst?

Do insiders & institutionals hold more shares of DRIO or HCAT?

Which has more volatility & risk, DRIO or HCAT?

Is DRIO or HCAT more profitable?

Does the media prefer DRIO or HCAT?

Do analysts recommend DRIO or HCAT?

Which has better valuation & earnings, DRIO or HCAT?

Summary

How does DarioHealth compare to OptimizeRx?

Do insiders & institutionals have more ownership in OPRX or DRIO?

Do analysts rate OPRX or DRIO?

Is OPRX or DRIO more profitable?

Which has more volatility and risk, OPRX or DRIO?

Does the media favor OPRX or DRIO?

Which has better earnings & valuation, OPRX or DRIO?

Summary

How does DarioHealth compare to CareCloud?

Does the media prefer CCLD or DRIO?

Do insiders and institutionals have more ownership in CCLD or DRIO?

Which has better valuation and earnings, CCLD or DRIO?

Do analysts prefer CCLD or DRIO?

Which has more risk and volatility, CCLD or DRIO?

Is CCLD or DRIO more profitable?

Summary

How does DarioHealth compare to Definitive Healthcare?

Which has better earnings and valuation, DRIO or DH?

Do institutionals and insiders hold more shares of DRIO or DH?

Is DRIO or DH more profitable?

Does the media refer more to DRIO or DH?

Do analysts prefer DRIO or DH?

Which has more volatility & risk, DRIO or DH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DRIO vs. The Competition

DarioHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools